| pubmed-article:20037303 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20037303 | lifeskim:mentions | umls-concept:C0007137 | lld:lifeskim |
| pubmed-article:20037303 | lifeskim:mentions | umls-concept:C0152018 | lld:lifeskim |
| pubmed-article:20037303 | lifeskim:mentions | umls-concept:C0016360 | lld:lifeskim |
| pubmed-article:20037303 | lifeskim:mentions | umls-concept:C1517927 | lld:lifeskim |
| pubmed-article:20037303 | lifeskim:mentions | umls-concept:C0205420 | lld:lifeskim |
| pubmed-article:20037303 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:20037303 | lifeskim:mentions | umls-concept:C0093999 | lld:lifeskim |
| pubmed-article:20037303 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:20037303 | pubmed:dateCreated | 2009-12-28 | lld:pubmed |
| pubmed-article:20037303 | pubmed:abstractText | Concurrent chemoradiotherapy (CRT) using cisplatin (CDDP) and 5-fluorouracil (5-FU) is the standard treatment for unresectable locally advanced esophageal carcinoma. Although this regimen has been widely accepted in Japan, the adverse effect of CDDP such as gastrointestinal and renal toxicity may sometimes be the cause of interruption of the treatment, especially among the elderly patients. Cis-diammine-glycolatoplatinum(nedaplatin: CDGP) is a new platinum agent, which was developed with the aim of decreasing renal and gastrointestinal toxicities but maintaining the effectiveness of CDDP. We reported the efficacy and safety of CRT using CDGP and 5-FU for locally advanced squamous cell carcinoma of the esopahagus. | lld:pubmed |
| pubmed-article:20037303 | pubmed:language | jpn | lld:pubmed |
| pubmed-article:20037303 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20037303 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20037303 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20037303 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20037303 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20037303 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20037303 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20037303 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20037303 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:20037303 | pubmed:issn | 0385-0684 | lld:pubmed |
| pubmed-article:20037303 | pubmed:author | pubmed-author:KuboNaoshiN | lld:pubmed |
| pubmed-article:20037303 | pubmed:author | pubmed-author:MaedaKiyoshiK | lld:pubmed |
| pubmed-article:20037303 | pubmed:author | pubmed-author:SawadaTetsuji... | lld:pubmed |
| pubmed-article:20037303 | pubmed:author | pubmed-author:YashiroMasaka... | lld:pubmed |
| pubmed-article:20037303 | pubmed:author | pubmed-author:OhiraMasaichi... | lld:pubmed |
| pubmed-article:20037303 | pubmed:author | pubmed-author:HirakawaKosei... | lld:pubmed |
| pubmed-article:20037303 | pubmed:author | pubmed-author:YamashitaYosh... | lld:pubmed |
| pubmed-article:20037303 | pubmed:author | pubmed-author:InoueToruT | lld:pubmed |
| pubmed-article:20037303 | pubmed:author | pubmed-author:YamadaNobuyaN | lld:pubmed |
| pubmed-article:20037303 | pubmed:author | pubmed-author:TanakaHiroaki... | lld:pubmed |
| pubmed-article:20037303 | pubmed:author | pubmed-author:MugurumaKazuy... | lld:pubmed |
| pubmed-article:20037303 | pubmed:author | pubmed-author:AmanoRyosukeR | lld:pubmed |
| pubmed-article:20037303 | pubmed:author | pubmed-author:NodaEijiE | lld:pubmed |
| pubmed-article:20037303 | pubmed:author | pubmed-author:MorimotoJunya... | lld:pubmed |
| pubmed-article:20037303 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:20037303 | pubmed:volume | 36 | lld:pubmed |
| pubmed-article:20037303 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20037303 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20037303 | pubmed:pagination | 1997-9 | lld:pubmed |
| pubmed-article:20037303 | pubmed:meshHeading | pubmed-meshheading:20037303... | lld:pubmed |
| pubmed-article:20037303 | pubmed:meshHeading | pubmed-meshheading:20037303... | lld:pubmed |
| pubmed-article:20037303 | pubmed:meshHeading | pubmed-meshheading:20037303... | lld:pubmed |
| pubmed-article:20037303 | pubmed:meshHeading | pubmed-meshheading:20037303... | lld:pubmed |
| pubmed-article:20037303 | pubmed:meshHeading | pubmed-meshheading:20037303... | lld:pubmed |
| pubmed-article:20037303 | pubmed:meshHeading | pubmed-meshheading:20037303... | lld:pubmed |
| pubmed-article:20037303 | pubmed:meshHeading | pubmed-meshheading:20037303... | lld:pubmed |
| pubmed-article:20037303 | pubmed:meshHeading | pubmed-meshheading:20037303... | lld:pubmed |
| pubmed-article:20037303 | pubmed:meshHeading | pubmed-meshheading:20037303... | lld:pubmed |
| pubmed-article:20037303 | pubmed:meshHeading | pubmed-meshheading:20037303... | lld:pubmed |
| pubmed-article:20037303 | pubmed:meshHeading | pubmed-meshheading:20037303... | lld:pubmed |
| pubmed-article:20037303 | pubmed:meshHeading | pubmed-meshheading:20037303... | lld:pubmed |
| pubmed-article:20037303 | pubmed:meshHeading | pubmed-meshheading:20037303... | lld:pubmed |
| pubmed-article:20037303 | pubmed:meshHeading | pubmed-meshheading:20037303... | lld:pubmed |
| pubmed-article:20037303 | pubmed:meshHeading | pubmed-meshheading:20037303... | lld:pubmed |
| pubmed-article:20037303 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:20037303 | pubmed:articleTitle | [Concurrent chemoradiotherapy with nedaplatin and 5-fluorouracil (5-fu) for locally advanced squamous cell carcinoma of the esophagus]. | lld:pubmed |
| pubmed-article:20037303 | pubmed:affiliation | Department of Surgical Oncology, Osaka City University Graduate School of Medicine, and Department of Digestive Surgery, Osaka City General Hospital. | lld:pubmed |
| pubmed-article:20037303 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20037303 | pubmed:publicationType | English Abstract | lld:pubmed |
